Genovo: A matter of scale By Kathryn Calkins
Staff writer

A continuing challenge to delivery of gene therapies has been the development of scaleable manufacturing systems for viral vectors. Genovo Inc. is concentrating on process development aspects of viral vector gene therapy through an alliance with the University of Pennsylvania's Institute for Human Gene Therapy (IHGT), which is directed by company founder James Wilson.